-+ 0.00%
-+ 0.00%
-+ 0.00%

Arcutis Biotherapeutics Reports Positive Phase 2 Results for ZORYVE Cream in Infants with Atopic Dermatitis

Reuters·02/02/2026 13:00:48

Please log in to view news